World J Gastroenterol (2005) 11(21):32226
Tirzepatide (Mounjaro) boasts around a 20% body weight loss in a year, and with it a slew of other benefits: reduced blood pressure, improved hemoglobin A1c levels, better cholesterol
US FDA, Dec 2024
Nutritional Risks of Combining Fasting and GLP-1 Therapy The biggest risk when merging intermittent fasting with GLP-1 use is consuming too few calories during eating windows, leading to protein deficiency, micronutrient gaps, and loss of lean muscle mass
These are vitamins, minerals, amino acids, antioxidants, and sometimes medications, either injected into the IV bag or pushed through the same line as a separate bolus
Retrieved from Vivus, LLC-b